132 related articles for article (PubMed ID: 8896416)
41. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
42. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
43. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
[TBL] [Abstract][Full Text] [Related]
44. Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells.
Liu YC; Elly C; Langdon WY; Altman A
J Biol Chem; 1997 Jan; 272(1):168-73. PubMed ID: 8995243
[TBL] [Abstract][Full Text] [Related]
45. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.
Ota S; Hazeki K; Rao N; Lupher ML; Andoniou CE; Druker B; Band H
J Biol Chem; 2000 Jan; 275(1):414-22. PubMed ID: 10617633
[TBL] [Abstract][Full Text] [Related]
46. Role of phosphatidylinositol 3-kinase in anti-IgM- and anti-IgD-induced apoptosis in B cell lymphomas.
Carey GB; Scott DW
J Immunol; 2001 Feb; 166(3):1618-26. PubMed ID: 11160203
[TBL] [Abstract][Full Text] [Related]
47. The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction.
Lupher ML; Rao N; Eck MJ; Band H
Immunol Today; 1999 Aug; 20(8):375-82. PubMed ID: 10431158
[TBL] [Abstract][Full Text] [Related]
48. c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway.
Ueno H; Sasaki K; Honda H; Nakamoto T; Yamagata T; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Blood; 1998 Jan; 91(1):46-53. PubMed ID: 9414268
[TBL] [Abstract][Full Text] [Related]
49. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.
O'Rourke LM; Tooze R; Turner M; Sandoval DM; Carter RH; Tybulewicz VL; Fearon DT
Immunity; 1998 May; 8(5):635-45. PubMed ID: 9620684
[TBL] [Abstract][Full Text] [Related]
50. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor.
Meisner H; Czech MP
J Biol Chem; 1995 Oct; 270(43):25332-5. PubMed ID: 7592693
[TBL] [Abstract][Full Text] [Related]
51. Regulation of beta 1-integrin-mediated cell adhesion by the Cbl adaptor protein.
Zell T; Warden CS; Chan AS; Cook ME; Dell CL; Hunt SW; Shimizu Y
Curr Biol; 1998 Jul; 8(14):814-22. PubMed ID: 9663390
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.
Kassenbrock CK; Hunter S; Garl P; Johnson GL; Anderson SM
J Biol Chem; 2002 Jul; 277(28):24967-75. PubMed ID: 11994282
[TBL] [Abstract][Full Text] [Related]
53. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells.
Marengère LE; Mirtsos C; Kozieradzki I; Veillette A; Mak TW; Penninger JM
J Immunol; 1997 Jul; 159(1):70-6. PubMed ID: 9200440
[TBL] [Abstract][Full Text] [Related]
54. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.
Chernock RD; Cherla RP; Ganju RK
Blood; 2001 Feb; 97(3):608-15. PubMed ID: 11157475
[TBL] [Abstract][Full Text] [Related]
55. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
Vilen BJ; Burke KM; Sleater M; Cambier JC
J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
[TBL] [Abstract][Full Text] [Related]
56. Signal transduction via the CD38/NAD+ glycohydrolase.
Kontani K; Kukimoto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Nishina H; Takahashi K; Hazeki O; Katada T
Adv Exp Med Biol; 1997; 419():421-30. PubMed ID: 9193684
[TBL] [Abstract][Full Text] [Related]
57. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus.
Vigorito E; Bardi G; Glassford J; Lam EW; Clayton E; Turner M
J Immunol; 2004 Sep; 173(5):3209-14. PubMed ID: 15322182
[TBL] [Abstract][Full Text] [Related]
58. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
59. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
60. FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates.
Lavagna-Sévenier C; Marchetto S; Birnbaum D; Rosnet O
Leukemia; 1998 Mar; 12(3):301-10. PubMed ID: 9529123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
